Table 2.
Bivariate correlations between VAT and SAT CDO1 mRNA and clinical and anthropometric parameters, and adipose tissue gene expression in cohort 1. These correlations were analysed using the nonparametric Spearman correlation coefficient.
| VAT CDO1 (RU) |
SAT CDO1 (RU) |
|||
|---|---|---|---|---|
| r | P | r | P | |
| Age (years) | −0.03 | 0.6 | −0.15 | 0.01 |
| BMI (kg/m2) | −0.05 | 0.4 | −0.07 | 0.2 |
| Fasting glucose (mg/dl) | −0.03 | 0.6 | −0.06 | 0.3 |
| HbA1c (%) | 0.01 | 0.8 | −0.15 | 0.01 |
| HDL-cholesterol (mg/dl) | 0.11 | 0.06 | 0.14 | 0.02 |
| Fasting triglycerides (mg/dl) | −0.15 | 0.009 | −0.18 | 0.002 |
| hsCRP (mg/dl) | −0.05 | 0.4 | −0.02 | 0.7 |
| CIDEA (RU) | 0.46 | <0.0001 | 0.30 | <0.0001 |
| PPARGC1A (RU) | 0.37 | <0.0001 | 0.35 | <0.0001 |
| UCP1 (RU) | 0.26 | <0.0001 | −0.04 | 0.5 |
| PRDM16 (RU) | 0.34 | <0.0001 | 0.16 | 0.008 |
| SLC2A4 (RU) | 0.40 | <0.0001 | 0.33 | <0.0001 |
| ADIPOQ (RU) | 0.58 | <0.0001 | 0.39 | <0.0001 |
| FASN (RU) | 0.43 | <0.0001 | 0.36 | <0.0001 |
| PLIN1 (RU) | 0.53 | <0.0001 | 0.36 | <0.0001 |
R.U., relative gene expression units to PPIA (endogenous control) gene expression.